Unravelling the Impact of Aberrant Expression of LncRNA-H19 in Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a highly aggressive hematologic malignancy marked by the proliferation of abnormal myeloid precursors. Despite therapeutic developments, the prognosis for AML patients remains poor, primarily due to high relapse frequencies and resistance to chemotherapy. Molecular alterations are a...